{"id":"W2011246519","doi":"10.3816/cgc.2005.n.002","title":"Combined Androgen Blockade: The Case for Bicalutamide","year":2005,"lang":"en","type":"review","venue":"Clinical Prostate Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Bicalutamide; Antiandrogen; Flutamide; Medicine; Prostate cancer; Castration; Urology; Antiandrogens; Internal medicine; Enzalutamide; Androgen; Oncology; Androgen receptor; Hazard ratio; Androgen deprivation therapy; Randomized controlled trial; Testosterone (patch); Combination therapy; Endocrinology; Cancer; Hormone; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007667664,0.0005678989,0.002340818,0.001298242,0.0002593622,0.0009200418,0.001251031,0.001443856,0.002676633],"category_scores_gemma":[0.001103348,0.0002514748,0.0006656012,0.001575423,0.0006042545,0.001098254,0.0004546428,0.002787175,0.001357136],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000670755,"about_ca_system_score_gemma":0.001008131,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001672237,"about_ca_topic_score_gemma":0.006602354,"domain_scores_codex":[0.9997093,0.00006794991,0.00005206424,0.00004966583,0.00009590821,0.00002498531],"domain_scores_gemma":[0.9994811,0.0003293326,0.00007767273,0.00001648563,0.00006488989,0.00003045687],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002136289,0.00003751857,0.000244334,0.00928745,0.0001859657,0.001741937,0.0000679288,0.0001817852,0.000835476,0.002353019,0.03775264,0.9470982],"study_design_scores_gemma":[0.0001518021,0.0001215355,0.001183845,0.006393574,0.0003869717,0.01168492,0.0001252362,0.000112184,0.0004406684,0.002367162,0.9770073,0.00002480005],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001600488,0.9981171,0.00009289961,0.000546822,0.0001613043,0.000002361483,0.000007599484,0.000005884609,0.0009059921],"genre_scores_gemma":[0.002116903,0.9952461,0.0003357248,0.001122762,0.0002986101,0.000005705346,0.00001995553,0.00000359763,0.0008506289],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002676633,"threshold_uncertainty_score":0.008954227,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2358887684497332,"score_gpt":0.5315328612553668,"score_spread":0.2956440928056336,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}